Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Grazoprevir

Grazoprevir (MK-5172) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Kis of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively[1][2]. Grazoprevir inhibits SARS-CoV-2 3CLpro activity[3].

Product Specifications

CAS Number

[1350514-68-9]

Product Name Alternative

MK-5172

UNSPSC

12352005

Hazard Statement

H303, H320

Target

HCV; HCV Protease; SARS-CoV

Type

Reference compound

Related Pathways

Anti-infection; Metabolic Enzyme/Protease

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/MK-5172.html

Purity

99.94

Solubility

DMSO : 50 mg/mL (ultrasonic) |Ethanol : 66.67 mg/mL (ultrasonic)

Smiles

COC1=CC2=C(N=C(CCCCC[C@@H]3C[C@H]3OC4=O)C(O[C@H]5CN(C([C@H](C(C)(C)C)N4)=O)[C@H](C(N[C@@]([C@@H]6C=C)(C6)C(NS(C7CC7)(=O)=O)=O)=O)C5)=N2)C=C1

Molecular Formula

C38H50N6O9S

Molecular Weight

766.90

Precautions

H303, H320

References & Citations

[1]Summa V, et al. MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants. Antimicrob Agents Chemother. 2012 Aug;56 (8) :4161-7.|[2]Harper S, et al. Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor. ACS Med Chem Lett. 2012 Mar 2;3 (4) :332-6.|[3]Qi Sun, et al. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct Target Ther. 2021 May 29;6 (1) :212.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Launched

Citation 01

Antivir Res. 2019 Nov;171:104612.|Antiviral Res. 2017 Mar;139:18-24. |Antiviral Res. 2022 Jan:197:105224.|bioRxiv. 2023 Feb 27:2023.02.27.530290.|bioRxiv. 2023 Oct 26:2023.10.26.561921.|bioRxiv. 2024 Dec 3:2024.11.26.625483.|bioRxiv. 2024 Mar 12.|Cancer Cell. 2022 Nov 14;40 (11) :1294-1305.e4.|Cancer Immunol Res. 2021 Sep;9 (9) :999-1007.|Development. 2025 May 16:dev.204505.|Elife. 2020 Jun 9:9:e56469.|J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Mar 15:1110-1111:15-24.|J Gastroenterol. 2019 May;54 (5) :449-458. |J Pharm Biomed Anal. 2020 Jan 30;178:112964.|Nat Biotechnol. 2019 Oct;37 (10) :1209-1216.|Nat Commun. 2020 Sep 4;11 (1) :4417.|Nat Methods. 2018 Jul;15 (7) :519-522.|Patent. US12065501.|Patent. US20180346589A1.|Patent. US20190010245A1.|Patent. US20220025003A1.|Pharmaceuticals (Basel) . 2022 Feb 18;15 (2) :242.|Research Square Preprint. 2024 Jan 23.|Sci Rep. 2022 Jul 16;12 (1) :12197.|Sci Rep. 2019 Apr 5;9 (1) :5722.|Signal Transduct Target Ther. 2021 May 29;6 (1) :212.|University of Glasgow. 2024 Mar.|Cancer Cell. 2022 Nov 14;40 (11) :1294-1305.e4.|Cancer Cell. 2024 Nov 11;42 (11) :1955-1969.e7.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

S100 Calcium Binding Protein A13 (S100A13) (NM_001024213) Human Tagged ORF Clone Lentiviral Particle
RC211720L3V 200 µL

S100 Calcium Binding Protein A13 (S100A13) (NM_001024213) Human Tagged ORF Clone Lentiviral Particle

Ask
View Details
MEK2 (MAP2K2) (NM_030662) Human Mutant ORF Clone
RC403508 10 µg

MEK2 (MAP2K2) (NM_030662) Human Mutant ORF Clone

Ask
View Details
Laminin (LAMC3) (NM_006059) Human Over-expression Lysate
LH08010V 100 µg

Laminin (LAMC3) (NM_006059) Human Over-expression Lysate

Ask
View Details
Himandridine
MF-0125495-01 10 mg

Himandridine

Ask
View Details
Himandridine
MF-0125495-02 50 mg

Himandridine

Ask
View Details
Phosphoribosyl pyrophosphate amidotransferase (PPAT) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1C7]
TA504481AM 100 µL

Phosphoribosyl pyrophosphate amidotransferase (PPAT) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1C7]

Ask
View Details